Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path.
Palliative terminal care
The aging population in the Netherlands and the increasing number of elderly living at home have led to a higher demand for palliative terminal care at home. Attenza provides this care to patients who wish to spend their last days at home with an intensive need for care. Attenza is able to quickly scale up or down palliative terminal care requests and is up to 24 hours per day available at the patient with a small team of care takers to provide comfort and quality care during the final stage of life. The company uses a proprietary software application, which contributes to the success and self-organization of the team, the quality of care and rapid deployment.
The partnership
Due to the partnership with Holland Capital Attenza can further expand its care services, resulting in nationwide coverage.
Carin van der Kaaden (Director of Attenza): “We are delighted to continue our passion together with Holland Capital. Enabling the highest possible quality of both living and dying at home with a small team of dedicated and well-trained professionals, for patients who have the last wish to pass away at home.”
Margot Engels (Partner Healthcare of Holland Capital): “We are proud to add Attenza to our portfolio of healthcare companies. We look forward to supporting the organization and its management in their growth ambitions.”
Almende has been involved in Attenza as a shareholder since 2017 and has actively supported the establishment and expansion of its proposition.
Jan Peter Larsen, CEO of Almende: “We are proud of the unique concept we have established with Attenza and the impact it has on people’s lives. The arrival of Holland Capital is the next step in Attenza’s ambition to offer this form of care nationwide.”
About Attenza
Attenza, founded in 2015, provides palliative terminal intensive care for individuals with specialized needs. Attenza’s mission is to ensure that everyone can spend their last weeks of their life comfortably at home. This is made possible through the swift and effective deployment of a small team of expert caregivers per patient.
About Holland Capital
Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 160 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare, Technology and Food & Agri. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful healthcare entrepreneurs in the relevant growth markets.
About Almende
Almende is a Rotterdam-based venture builder that focuses on self-organization and technological innovation with a significant societal impact. With over 20 years of experience, Almende has created and scaled successful startups and scaleups in the fields of robotics, communication, and healthcare.
Holland Capital sluit partnership met NL Cares
Holland Capital sluit partnership met NL Cares Amsterdam, 21 april 2022 - Met veel plezier kondigen wij onze samenwerking met NL Cares aan, een vrijwilligersorganisatie die zichzelf als doel stelt om te bouwen aan een zorgzame samenleving. Met elkaar kunnen we impact...
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems
Live-Cell Imaging Innovator CytoSMART Technologies Has Been Acquired by Axion BioSystems Amsterdam, 21 March 2022 – We’re proud to announce that our portfolio company, CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis, has been acquired by...
YOEP Onderwijs & Zorg joins forces with Ad Astra
YOEP Onderwijs & Zorg joins forces with Ad Astra Amsterdam, 14th of March 2022, Our portfolio company YOEP Onderwijs en Zorg is joining forces with Ad Astra Begeleiding & Behandeling, a youth care provider which focuses on the guidance and treatment of...
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra
YOEP Onderwijs en Zorg bundelt krachten met Ad Astra Amsterdam, 14 maart 2022 – Onze deelneming YOEP Onderwijs en Zorg gaat samenwerken met Ad Astra begeleiding & behandeling, een jeugdzorgaanbieder die zich richt op de begeleiding en behandeling van kinderen en...
Axual haalt groeifinanciering op bij investeerder Holland Capital
Axual haalt groeifinanciering op bij investeerder Holland Capital Utrecht/Amsterdam, 10 maart 2022 – Holland Capital investeert met een private co-investeerder in softwarebedrijf Axual, dat klanten voorziet van een platform dat real-time data streaming eenvoudiger en...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl